#BEGIN_DRUGCARD DB02042

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C11H24O6

# Chemical_IUPAC_Name:
2,5,8,11,14-pentaoxahexadecan-16-ol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol

# HET_ID:
1PG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C11H24O6/c1-13-4-5-15-8-9-17-11-10-16-7-6-14-3-2-12/h12H,2-11H2,1H3

# InChI_Key:
InChIKey=SLNYBUIEAMRFSZ-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2042

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
252.3047

# Molecular_Weight_Mono:
252.1572885

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1PL3

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.42

# Predicted_LogS:
-1.8

# Predicted_Water_Solubility:
4.22e+00 g/l

# Primary_Accession_No:
DB02042

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
90255

# PubChem_Substance_ID:
46507262

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00082

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
COCCOCCOCCOCCOCCO

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:44 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X58833

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
actVA 6

# Drug_Target_1_Gene_Sequence:
>342 bp
ATGGCTGAAGTGAACGATCCCCGGGTGGGCTTCGTCGCGGTCGTCACCTTCCCGGTGGAC
GGCCCCGCCACCCAGCACAAGCTGGTGGAGCTGGCCACCGGCGGGGTGCAGGAGTGGATC
CGCGAGGTGCCCGGCTTCCTGTCGGCCACGTATCACGCGAGCACGGACGGGACCGCGGTC
GTCAACTACGCCCAGTGGGAGAGCGAGCAGGCCTACCGGGTGAACTTCGGCGCCGACCCG
CGCTCGGCGGAGCTGCGGGAGGCGCTGAGCTCGCTGCCCGGGCTCATGGGGCCGCCGAAG
GCCGTGTTCATGACTCCGCGGGGGGCGATCCTGCCGTCCTGA

# Drug_Target_1_General_Function:
Involved in oxidoreductase activity

# Drug_Target_1_General_References:
12000953	Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra G, Chen CW, Collins M, Cronin A, Fraser A, Goble A, Hidalgo J, Hornsby T, Howarth S, Huang CH, Kieser T, Larke L, Murphy L, Oliver K, O'Neil S, Rabbinowitsch E, Rajandream MA, Rutherford K, Rutter S, Seeger K, Saunders D, Sharp S, Squares R, Squares S, Taylor K, Warren T, Wietzorrek A, Woodward J, Barrell BG, Parkhill J, Hopwood DA: Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature. 2002 May 9;417(6885):141-7.
1766437	Caballero JL, Martinez E, Malpartida F, Hopwood DA: Organisation and functions of the actVA region of the actinorhodin biosynthetic gene cluster of Streptomyces coelicolor. Mol Gen Genet. 1991 Dec;230(3):401-12.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4283

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
12100

# Drug_Target_1_Name:
ActVA 6 protein

# Drug_Target_1_Number_of_Residues:
113

# Drug_Target_1_PDB_ID:
1N5V

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF03992	ABM

# Drug_Target_1_Protein_Sequence:
>ActVA 6 protein
MAEVNDPRVGFVAVVTFPVDGPATQHKLVELATGGVQEWIREVPGFLSATYHASTDGTAV
VNYAQWESEQAYRVNFGADPRSAELREALSSLPGLMGPPKAVFMTPRGAILPS

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q53908

# Drug_Target_1_SwissProt_Name:
Q53908_STRCO

# Drug_Target_1_Synonyms:
Hypothetical protein SCO5081

# Drug_Target_1_Theoretical_pI:
4.75

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AB001488

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
ndoA

# Drug_Target_2_Gene_Sequence:
>351 bp
TTGATTGTGAAACGCGGCGATGTTTATTTTGCTGATTTATCTCCTGTTGTTGGCTCAGAG
CAAGGCGGGGTGCGCCCGGTTTTAGTGATCCAAAATGACATCGGAAATCGCTTCAGCCCA
ACTGCTATTGTTGCAGCCATAACAGCACAAATACAGAAAGCGAAATTACCAACCCACGTC
GAAATCGATGCAAAACGCTACGGTTTTGAAAGAGATTCCGTTATTTTGCTGGAGCAAATT
CGGACGATTGACAAGCAAAGGTTAACGGATAAGATTACTCATCTGGATGATGAAATGATG
GATAAGGTTGATGAAGCCTTACAAATCAGTTTGGCACTCATTGATTTTTAG

# Drug_Target_2_General_Function:
Involved in DNA binding

# Drug_Target_2_General_References:
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
4590

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
12978

# Drug_Target_2_Name:
Endoribonuclease EndoA

# Drug_Target_2_Number_of_Residues:
116

# Drug_Target_2_PDB_ID:
1NE8

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF02452	PemK

# Drug_Target_2_Protein_Sequence:
>Endoribonuclease EndoA
MIVKRGDVYFADLSPVVGSEQGGVRPVLVIQNDIGNRFSPTAIVAAITAQIQKAKLPTHV
EIDAKRYGFERDSVILLEQIRTIDKQRLTDKITHLDDEMMDKVDEALQISLALIDF

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Yields cleavage products with 3' phosphate and 5' hydroxyl groups. Overexpression is toxic for cell growth, probably by inhibiting protein synthesis through the cleavage of single- stranded RNA. The toxicity is reversed by the antitoxin EndoAI

# Drug_Target_2_SwissProt_ID:
P96622

# Drug_Target_2_SwissProt_Name:
ENDOA_BACSU

# Drug_Target_2_Synonyms:
EC 3.1.-.-

# Drug_Target_2_Theoretical_pI:
4.88

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB02042
